Spero Therapeutics, Inc. (NASDAQ:SPRO) Q1 2023 Earnings Call Transcript

Spero Therapeutics, Inc. (NASDAQ:SPRO) Q1 2023 Earnings Call Transcript May 11, 2023

Spero Therapeutics, Inc. beats earnings expectations. Reported EPS is $-0.25, expectations were $-0.33.

Operator: Good afternoon, and welcome to the Spero Therapeutics First Quarter 2023 Financial Results Conference Call. At this time, all participants are in listen-only mode. Following the company’s formal remarks, we will open up the call for questions. [Operator Instructions] Please be advised that this...